Episode Details
Back to Episodes
Join Study on New Weight Loss Drug
Description
Want to be part of groundbreaking weight loss research? Pennington Biomedical’s NOVO Expenditure study, led by Dr. Eric Ravussin, is recruiting adults aged 18–65 with BMI over 30 to test a new metabolic drug. Participants will stay overnight at the clinic, wear a wrist tracker, and provide tissue samples. The study has two phases: first, you’ll get either the drug or a diet; then everyone gets the drug. It’s a big commitment—but could help science AND you.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/c238597353eaeac2